Amplification of a particular DNA sequence in Streptomyces ambofaciens RP181110 reversibly prevents spiramycin production.

Abstract : Streptomyces ambofaciens RP181110 produces the macrolide antibiotic spiramycin. After treatment with ethidium bromide, 7 strains presenting an amplified sequence of DNA (ADS) were found in its progeny. These ADS were localized within the same amplifiable region of the RP181110 genome. It has been established that these amplified strains were non-producers (Spi-) and that the loss of one particular ADS was correlated with restoration of spiramycin production. Genome rearrangements such as deletions were detected on the same side of the amplifiable region in both amplified and deamplified strains.
Type de document :
Article dans une revue
Research in Microbiology, Elsevier, 1992, pp.99-112
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01625476
Contributeur : Nathalie Leblond-Bourget <>
Soumis le : vendredi 27 octobre 2017 - 16:10:04
Dernière modification le : vendredi 29 juin 2018 - 09:18:02

Identifiants

  • HAL Id : hal-01625476, version 1
  • PUBMED : 1641517

Collections

Citation

A Dary, N Bourget, N Girard, J M Simonet, B Decaris. Amplification of a particular DNA sequence in Streptomyces ambofaciens RP181110 reversibly prevents spiramycin production.. Research in Microbiology, Elsevier, 1992, pp.99-112. 〈hal-01625476〉

Partager

Métriques

Consultations de la notice

21